“Luminal breast epithelial cells of BRCA1 or BRCA2 mutation carriers and noncarriers harbor common breast cancer copy number alterations” (Dec 11, 2024)
“Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment” (Jun 20, 2024)
“Single-cell mtDNA dynamics in tumors is driven by coregulation of nuclear and mitochondrial genomes” (May 16, 2024)
“Disentangling oncogenic amplicons in esophageal adenocarcinoma” (May 15, 2024)
Research Experience
Principal investigator of the Aparicio Lab located at BC Cancer Agency, Vancouver
Conducts research on cancer evolution through temporal and spatial multi-sample studies
Tracks clonal dynamics via time-series biopsies, patient-derived xenografts (PDX), and anatomical spread of clones
Pioneers single-cell genomics using optimized biophysical techniques and hidden Markov models for accurate copy number profiling
Develops phylogenetic and fitness computational models to analyze population dynamics of thousands of cancer cells under genetic or pharmacologic perturbations
Background
Leads an international cancer biology and genomics lab
Dedicated to dissecting fundamental properties of cancer evolution and developing novel therapies
Uses high-resolution genomics and genetics to study human cancers
Integrates innovative computational methods to infer cancer biology at genome and single-cell scales
Translates research findings into new cancer therapeutics